The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck

993 000 € was granted to a research project led by our Group Leader Professor Jukka Westermarck titled “Small-molecule targeting and nuclear functions of CIP2A in triple-negative breast cancer.” The project aims to advance the treatment of triple-negative breast cancer by developing small-molecule compounds that target the CIP2A protein. Triple-negative breast cancer is one of the […]